Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA, Mitochondrial | 10 | 2025 | 191 | 1.690 |
Why?
|
| DNA Damage | 12 | 2025 | 356 | 1.650 |
Why?
|
| Huntington Disease | 5 | 2016 | 31 | 1.020 |
Why?
|
| Mitochondria | 6 | 2021 | 523 | 0.900 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 3 | 2025 | 19 | 0.740 |
Why?
|
| Oxidative Stress | 8 | 2016 | 1003 | 0.710 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2014 | 247 | 0.560 |
Why?
|
| DNA Repair | 6 | 2025 | 198 | 0.500 |
Why?
|
| Cyclic N-Oxides | 4 | 2016 | 19 | 0.440 |
Why?
|
| Hydroxycholesterols | 4 | 1999 | 18 | 0.420 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2014 | 203 | 0.380 |
Why?
|
| Neostriatum | 1 | 2012 | 28 | 0.370 |
Why?
|
| Mitochondria, Liver | 1 | 2011 | 15 | 0.360 |
Why?
|
| Apoptosis | 5 | 2000 | 1568 | 0.290 |
Why?
|
| Azoxymethane | 2 | 2025 | 9 | 0.270 |
Why?
|
| Liver | 2 | 2025 | 511 | 0.260 |
Why?
|
| Polymerase Chain Reaction | 3 | 2014 | 455 | 0.250 |
Why?
|
| Aging | 1 | 2011 | 783 | 0.240 |
Why?
|
| Gene Expression Regulation | 3 | 1999 | 1070 | 0.200 |
Why?
|
| Sterols | 2 | 1999 | 24 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 1999 | 63 | 0.180 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 60 | 0.180 |
Why?
|
| Motor Activity | 2 | 2016 | 437 | 0.180 |
Why?
|
| Animals | 14 | 2025 | 16992 | 0.170 |
Why?
|
| Cholesterol | 2 | 2000 | 232 | 0.170 |
Why?
|
| Genes, myc | 2 | 2000 | 31 | 0.160 |
Why?
|
| Mitochondrial ADP, ATP Translocases | 1 | 2019 | 8 | 0.160 |
Why?
|
| Electron Transport | 1 | 2019 | 47 | 0.150 |
Why?
|
| Mice | 7 | 2025 | 6644 | 0.140 |
Why?
|
| Housing, Animal | 1 | 2018 | 12 | 0.140 |
Why?
|
| Mitochondria, Heart | 2 | 2019 | 60 | 0.140 |
Why?
|
| Cell Nucleus | 3 | 2016 | 383 | 0.140 |
Why?
|
| Sunlight | 1 | 2018 | 48 | 0.140 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 1596 | 0.140 |
Why?
|
| Time Factors | 3 | 2014 | 1857 | 0.130 |
Why?
|
| Down-Regulation | 1 | 1999 | 456 | 0.130 |
Why?
|
| Glutathione Reductase | 1 | 2016 | 19 | 0.120 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2016 | 17 | 0.120 |
Why?
|
| Vitamin D | 1 | 2018 | 196 | 0.120 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 465 | 0.120 |
Why?
|
| Macaca mulatta | 2 | 2018 | 139 | 0.120 |
Why?
|
| Plasmodium berghei | 1 | 2016 | 34 | 0.120 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2015 | 3 | 0.120 |
Why?
|
| Glutathione | 1 | 2016 | 171 | 0.110 |
Why?
|
| Hydrogen Peroxide | 2 | 2014 | 190 | 0.110 |
Why?
|
| Malaria | 1 | 2016 | 90 | 0.110 |
Why?
|
| Humans | 14 | 2021 | 43102 | 0.110 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 64 | 0.110 |
Why?
|
| Cardiotonic Agents | 1 | 2014 | 40 | 0.110 |
Why?
|
| Zinc Fingers | 1 | 1994 | 28 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 5 | 2000 | 508 | 0.110 |
Why?
|
| Male | 9 | 2025 | 23409 | 0.100 |
Why?
|
| Myocardial Ischemia | 1 | 2014 | 83 | 0.100 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 532 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 1999 | 1271 | 0.100 |
Why?
|
| Lymphocytes | 1 | 1994 | 124 | 0.100 |
Why?
|
| Antioxidants | 2 | 2016 | 443 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2025 | 1869 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 1994 | 161 | 0.090 |
Why?
|
| Autopsy | 1 | 2012 | 48 | 0.090 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 1997 | 41 | 0.090 |
Why?
|
| Protein Carbonylation | 1 | 2011 | 8 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2013 | 187 | 0.090 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2011 | 12 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 218 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 719 | 0.090 |
Why?
|
| Catalase | 1 | 2011 | 110 | 0.090 |
Why?
|
| Glutathione Peroxidase | 1 | 2011 | 112 | 0.090 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 140 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 512 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1285 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 457 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2012 | 281 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 1994 | 561 | 0.080 |
Why?
|
| Cell Survival | 4 | 2012 | 945 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 386 | 0.080 |
Why?
|
| DNA, Neoplasm | 3 | 1998 | 92 | 0.080 |
Why?
|
| DNA Fragmentation | 3 | 2000 | 98 | 0.070 |
Why?
|
| Gene Expression | 1 | 2012 | 701 | 0.070 |
Why?
|
| Glucocorticoids | 2 | 1999 | 91 | 0.070 |
Why?
|
| Carcinogens | 2 | 2017 | 126 | 0.070 |
Why?
|
| Mutation | 1 | 2012 | 1177 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2019 | 90 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2000 | 592 | 0.060 |
Why?
|
| Receptors, Steroid | 2 | 1999 | 38 | 0.060 |
Why?
|
| DNA | 2 | 2000 | 592 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 3156 | 0.060 |
Why?
|
| Cell Line | 3 | 2019 | 1410 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2000 | 1124 | 0.050 |
Why?
|
| Cell Division | 3 | 2000 | 311 | 0.050 |
Why?
|
| Weight Loss | 2 | 2016 | 137 | 0.050 |
Why?
|
| Rats | 2 | 2019 | 3735 | 0.050 |
Why?
|
| Middle Aged | 2 | 2014 | 12222 | 0.050 |
Why?
|
| Methyl Methanesulfonate | 1 | 2000 | 6 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2000 | 29 | 0.040 |
Why?
|
| Alkylating Agents | 1 | 2000 | 14 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2000 | 68 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2000 | 95 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2016 | 1621 | 0.040 |
Why?
|
| Magnesium | 1 | 2000 | 94 | 0.040 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 141 | 0.040 |
Why?
|
| Female | 3 | 2015 | 24698 | 0.040 |
Why?
|
| Kinetics | 2 | 2000 | 695 | 0.040 |
Why?
|
| Electron Transport Complex I | 1 | 2019 | 29 | 0.040 |
Why?
|
| Mitochondrial Membranes | 1 | 2019 | 41 | 0.040 |
Why?
|
| Temperature | 1 | 2000 | 313 | 0.040 |
Why?
|
| Leukemia, Lymphoid | 1 | 1999 | 2 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 189 | 0.040 |
Why?
|
| Half-Life | 1 | 1999 | 63 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2000 | 232 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1999 | 31 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1999 | 150 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 1998 | 61 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 1999 | 127 | 0.040 |
Why?
|
| Caspases | 1 | 1999 | 148 | 0.040 |
Why?
|
| Caribbean Region | 1 | 2018 | 79 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 1998 | 80 | 0.030 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1997 | 8 | 0.030 |
Why?
|
| Caspase 1 | 1 | 1997 | 16 | 0.030 |
Why?
|
| Clone Cells | 1 | 1997 | 50 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2000 | 460 | 0.030 |
Why?
|
| Adult | 1 | 2014 | 13872 | 0.030 |
Why?
|
| Nucleosomes | 1 | 1997 | 30 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 183 | 0.030 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 16 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 64 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1997 | 210 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1997 | 55 | 0.030 |
Why?
|
| Neurons | 2 | 2016 | 1263 | 0.030 |
Why?
|
| Estradiol | 1 | 1998 | 268 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1999 | 883 | 0.030 |
Why?
|
| Life Cycle Stages | 1 | 2016 | 29 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 53 | 0.030 |
Why?
|
| Thioredoxins | 1 | 2016 | 41 | 0.030 |
Why?
|
| DNA Glycosylases | 1 | 2015 | 17 | 0.030 |
Why?
|
| Protein Binding | 1 | 1999 | 1082 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 665 | 0.030 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2014 | 34 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 110 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 127 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 258 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2014 | 107 | 0.030 |
Why?
|
| Cell Separation | 1 | 1994 | 94 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1994 | 96 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2016 | 373 | 0.020 |
Why?
|
| Cell Death | 1 | 1994 | 278 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 667 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2012 | 75 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 1035 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 291 | 0.020 |
Why?
|
| Aged | 1 | 2014 | 8214 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 138 | 0.010 |
Why?
|
| Leukemia | 1 | 2000 | 54 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 1998 | 21 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1998 | 56 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1998 | 40 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1998 | 55 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1998 | 53 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 458 | 0.010 |
Why?
|
| Cricetinae | 1 | 1998 | 241 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 1998 | 83 | 0.010 |
Why?
|
| Kidney | 1 | 1998 | 372 | 0.010 |
Why?
|